Unknown PHASE3 INTERVENTIONAL 2-arm NCT02449070

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction : A Randomized Clinical Trial

Sponsor: JW Pharmaceutical

Conditions Myocardial Infarction

Interventions Nicorandil

Updated 9 times since 2017 Last updated: Sep 18, 2017 Started: May 31, 2015 Primary completion: Oct 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02449070, this PHASE3 trial focuses on Myocardial Infarction and remains ongoing. Sponsored by JW Pharmaceutical, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Oct 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting PHASE3
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Unknown Status → Recruiting
Jun 2017 — Oct 2017 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE3

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Pharmaceutical
Pusan National University Hospital

Data source: Pusan National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pusan, South Korea